ADAR and glioblastoma: The first analyzed RNA-seq dataset consisting of two samples per set is known to show a strong reduction of A-to-I editing upon siRNA-induced ADAR1 knockdown (KD) in the glioblastoma cell line U87MG when compared to a control group16.